ZA975416B - Novel compounds - Google Patents

Novel compounds

Info

Publication number
ZA975416B
ZA975416B ZA975416A ZA975416A ZA975416B ZA 975416 B ZA975416 B ZA 975416B ZA 975416 A ZA975416 A ZA 975416A ZA 975416 A ZA975416 A ZA 975416A ZA 975416 B ZA975416 B ZA 975416B
Authority
ZA
South Africa
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
ZA975416A
Other languages
English (en)
Inventor
Steven Mark Bromidge
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA975416B publication Critical patent/ZA975416B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA975416A 1996-06-20 1997-06-19 Novel compounds ZA975416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612885.5A GB9612885D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
ZA975416B true ZA975416B (en) 1999-01-25

Family

ID=10795577

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975416A ZA975416B (en) 1996-06-20 1997-06-19 Novel compounds

Country Status (28)

Country Link
US (2) US6313145B1 (no)
EP (1) EP0912556B1 (no)
JP (1) JP2000512644A (no)
KR (1) KR20040101563A (no)
CN (1) CN1147485C (no)
AR (1) AR008244A1 (no)
AT (1) ATE196766T1 (no)
AU (1) AU718000B2 (no)
BR (1) BR9709982A (no)
CA (1) CA2258559A1 (no)
CO (1) CO4870758A1 (no)
CZ (1) CZ289799B6 (no)
DE (1) DE69703242T2 (no)
DK (1) DK0912556T3 (no)
ES (1) ES2152682T3 (no)
GB (1) GB9612885D0 (no)
GR (1) GR3034847T3 (no)
HK (1) HK1019744A1 (no)
HU (1) HUP9903480A3 (no)
IL (1) IL127304A (no)
NO (1) NO316756B1 (no)
NZ (1) NZ332840A (no)
PL (1) PL186885B1 (no)
PT (1) PT912556E (no)
TR (1) TR199802552T2 (no)
TW (1) TW360650B (no)
WO (1) WO1997048700A1 (no)
ZA (1) ZA975416B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710523D0 (en) * 1997-05-23 1997-07-16 Smithkline Beecham Plc Novel compounds
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
AU2002346507A1 (en) 2001-11-28 2003-06-10 Pharmacia And Upjohn Company Benzazepine derivatives and their use as 5-ht ligands
GB0200283D0 (en) * 2002-01-08 2002-02-20 Smithkline Beecham Plc Compounds
JP2006506319A (ja) 2002-03-04 2006-02-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 5−ht受容体リガンドとしてのピリジニルオキシ誘導体
EP1497265B1 (en) * 2002-04-19 2009-02-18 Glaxo Group Limited Compounds having affinity at 5ht2c receptor and use thereof in therapy
GB0305024D0 (en) * 2003-03-05 2003-04-09 Glaxo Group Ltd Compounds
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
KR20110114664A (ko) 2009-01-16 2011-10-19 메사추세츠 인스티튜트 오브 테크놀로지 자폐 스펙트럼 장애의 진단 및 치료

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4704693A (en) 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
ES2151652T3 (es) * 1995-02-02 2001-01-01 Smithkline Beecham Plc Derivados de indol como antagonistas del receptor 5ht.
EP0807104A2 (en) 1995-02-02 1997-11-19 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
GB9607219D0 (en) 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP

Also Published As

Publication number Publication date
EP0912556A1 (en) 1999-05-06
JP2000512644A (ja) 2000-09-26
CN1222152A (zh) 1999-07-07
CZ289799B6 (cs) 2002-04-17
GB9612885D0 (en) 1996-08-21
PT912556E (pt) 2001-02-28
US6313145B1 (en) 2001-11-06
IL127304A (en) 2003-07-06
US20020035134A1 (en) 2002-03-21
PL186885B1 (pl) 2004-03-31
DE69703242T2 (de) 2001-03-08
HK1019744A1 (en) 2000-02-25
HUP9903480A2 (en) 2000-07-28
KR20040101563A (ko) 2004-12-02
DK0912556T3 (da) 2001-01-22
TR199802552T2 (xx) 1999-02-22
AU3339697A (en) 1998-01-07
HUP9903480A3 (en) 2002-12-28
WO1997048700A1 (en) 1997-12-24
TW360650B (en) 1999-06-11
NO316756B1 (no) 2004-04-26
DE69703242D1 (de) 2000-11-09
NO985970L (no) 1998-12-18
AU718000B2 (en) 2000-04-06
IL127304A0 (en) 1999-09-22
CN1147485C (zh) 2004-04-28
PL330708A1 (en) 1999-05-24
NZ332840A (en) 2000-05-26
GR3034847T3 (en) 2001-02-28
CO4870758A1 (es) 1999-12-27
ES2152682T3 (es) 2001-02-01
EP0912556B1 (en) 2000-10-04
BR9709982A (pt) 1999-08-10
CZ420498A3 (cs) 1999-05-12
AR008244A1 (es) 1999-12-29
NO985970D0 (no) 1998-12-18
ATE196766T1 (de) 2000-10-15
CA2258559A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
EP0961618A4 (en) NEW COMPOUNDS
EP0909181A4 (en) NEW COMPOUNDS
GB9601067D0 (en) Novel compounds
EP0904105A4 (en) NEW COMPOUNDS
AP9701047A0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9612885D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
GB9601068D0 (en) Novel compounds
EP0907377A4 (en) NEW CONNECTIONS
GB9601066D0 (en) Novel compounds
GB9606208D0 (en) Novel compounds
GB9601099D0 (en) Novel compounds
GB9604574D0 (en) Novel compounds
GB9601095D0 (en) Novel compounds
GB9604580D0 (en) Novel compounds
GB9601096D0 (en) Novel compounds
GB9604417D0 (en) Novel compounds
GB9604599D0 (en) Novel compounds
GB9603689D0 (en) Novel compounds